Length gain, cm/week (high MCT vs low MCT) · promoting short‐term growth of preterm infants
1 finding from 1 review
Growth: head circumference (cm/week) · promoting short‐term growth of preterm infants
1 finding from 1 review
Skinfold thickness gain (mm/week) (high MCT vs low MCT) · promoting short‐term growth of preterm infants
1 finding from 1 review
Gastrointestinal intolerance · promoting short‐term growth of preterm infants
1 finding from 1 review
NEC · promoting short‐term growth of preterm infants
1 finding from 1 review
Neurodevelopmental outcomes · promoting short‐term growth of preterm infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Long‐term growth outcomes · promoting short‐term growth of preterm infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of cases of dementia Range of · participants without prior cerebrovascular disease for prevention of cognitive impairment and dementia
It is very uncertain whether antihypertensive therapy changes number of cases of dementia Range of compared with placebo (very low certainty).
1 finding from 1 review
Change in MMSE · participants without prior cerebrovascular disease for prevention of cognitive impairment and dementia
1 finding from 1 review
Adverse effects Range of · participants without prior cerebrovascular disease for prevention of cognitive impairment and dementia
1 finding from 1 review
Quality of life measured via Sickness Impact Profile, PGWB Positive well‐being, and EuroQoL Current Health Range of · participants without prior cerebrovascular disease for prevention of cognitive impairment and dementia
1 finding from 1 review
Quality of life · adults with psychotic depression
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acceptability ‐ dropouts due to adverse effects · adults with psychotic depression
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Leaving the study early · adults with psychotic depression
It is very uncertain whether antipsychotic changes overall dropouts compared with placebo (very low certainty).
1 finding from 1 review
Adverse events Study reports · adults with Major Depressive Disorder
It is very uncertain whether n3PUFAs changes adverse eventsStudy reports compared with placebo (very low certainty).
1 finding from 1 review
Quality of lifeValidated quality of life scales as used by authors, CGI (7‐point scale) where possible, higher scores indicate poorer quality of life · adults with Major Depressive Disorder
1 finding from 1 review
Trial non‐completionStudy reports · adults with Major Depressive Disorder
It is very uncertain whether n3PUFAs changes trial non‐completionStudy reports compared with placebo (very low certainty).
1 finding from 1 review
Intervention not reported
Time taken to establish full gavage feeding (days) · intermittent bolus gavage tube feeding of preterm and low birth weight infants
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Intervention not reported
Feeding intolerance (number of episodes per day) · intermittent bolus gavage tube feeding of preterm and low birth weight infants
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Intervention not reported
Respiratory rate (breaths per minute) at completion of feed · intermittent bolus gavage tube feeding of preterm and low birth weight infants
1 finding from 1 review